Stock 4565 NXERA PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Nxera Pharma Co., Ltd.

Equities

4565

JP3431300007

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
1,458 JPY -2.47% Intraday chart for Nxera Pharma Co., Ltd. +0.55% +2.60%
Apr. 18 Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May MT
Apr. 17 Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test MT

Evolution of the average Target Price on Nxera Pharma Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

7e6d2c56c87ba87b77aa6bcb.98jyw1F1J8bt-7WhQcC1ypkihDrkGZ82YZiZJl2YDP0.lPGqpAQ9Vre11oGWEpnGq8N31VyxQO1kD_70YxnwaoWGuoKwJwEUsJe2wg~6a0bf2ac45bc7176fd85a295340bbaa7

Analyst Recommendations on Nxera Pharma Co., Ltd.

Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May MT
Jefferies Adjusts Sosei Group’s Price Target to 2,100 Yen From 1,800 Yen, Keeps at Buy MT
Jefferies Adjusts Sosei Group's Price Target to 1,800 Yen From 1,700 Yen, Keeps at Buy MT
Jefferies Upgrades Sosei to Buy From Hold, Adjusts Price Target to 1,700 Yen From 1,600 Yen MT
Jefferies Downgrades Sosei Group Corporation to Underperform From Buy, Adjusts Price Target to 1,800 Yen From 4,200 Yen MT
Jefferies Adjusts Sosei’s Price Target to 4,200 Yen From 4,000 Yen, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1,458 JPY
Average target price
2,100 JPY
Spread / Average Target
+44.03%
High Price Target
3,900 JPY
Spread / Highest target
+167.49%
Low Price Target
1,500 JPY
Spread / Lowest Target
+2.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nxera Pharma Co., Ltd.

Jefferies & Co.

Ratings for Nxera Pharma Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4565 Stock
  4. Consensus Nxera Pharma Co., Ltd.